Global Information
회사소개 | 문의 | 비교리스트

세계의 줄기세포 치료 시장(2021-2027년) : 시장 예측(종류, 치료 영역, 최종사용자별), COVID-19의 영향, 지역적 전망, 기술 잠재성, 시장 점유율

Stem Cell Therapy Market Size By Type, By Therapeutic Area, End-use, COVID-19 Impact Analysis, Regional Outlook, Technology Potential, Competitive Market Share & Forecast, 2021 - 2027

리서치사 Global Market Insights Inc.
발행일 2021년 12월 상품코드 1043967
페이지 정보 영문 110 Pages 배송안내 2-3일 (영업일 기준)
가격
US $ 5,150 ₩ 6,549,000 Unprintable PDF (Single User License)
US $ 7,150 ₩ 9,092,000 Printable PDF (Multi User License)
US $ 9,150 ₩ 11,636,000 Printable PDF (Enterprise User License)


세계의 줄기세포 치료 시장(2021-2027년) : 시장 예측(종류, 치료 영역, 최종사용자별), COVID-19의 영향, 지역적 전망, 기술 잠재성, 시장 점유율 Stem Cell Therapy Market Size By Type, By Therapeutic Area, End-use, COVID-19 Impact Analysis, Regional Outlook, Technology Potential, Competitive Market Share & Forecast, 2021 - 2027
발행일 : 2021년 12월 페이지 정보 : 영문 110 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

줄기세포 치료 시장은 주요 지역에서 행해지고 있는 R&D와 최근의 재생의료 발전에 의해 2027년까지 대폭적인 성장을 나타낼 것으로 예측됩니다.

유형별로는 자가 세포 부문이 2027년 말까지 약 110억 달러 규모를 나타낼 것으로 예측됩니다. 치료 영역별로는 정형외과 부문이 2020년에 약 8억 5,050만 달러 규모를 나타냈고, 앞으로도 꾸준한 성장이 전망되고 있습니다. 최종사용자별로는 클리닉 부문이 2027년까지 약 10.8%의 연평균 복합 성장률(CAGR)로 성장하며 큰 매출을 올릴 것으로 예측됩니다.

세계의 줄기세포 치료(Stem Cell Therapy) 시장을 조사했으며, 시장의 정의와 개요, 코로나19(COVID-19) 및 기타 시장 영향요인 분석, 법규제 환경, 기술 미치 혁신 동향, 시장 규모 추이와 예측, 종류·치료 영역·최종사용자·지역/주요 국가 등 각종 구분별 분석, 경쟁 환경, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

제1장 조사 방법

제2장 개요

제3장 줄기세포 치료 산업 인사이트

  • 산업 분류
  • 산업 상황
  • 산업 영향요인
    • 성장요인
    • 잠재적 리스크&과제
  • 성장 가능성
  • COVID-19 : 영향 분석
  • 생태계 분석
  • Porter의 산업 분석
  • 경쟁 구도
  • 기업 매트릭스 분석
  • PESTEL 분석

제4장 줄기세포 치료 시장 : 유형별

  • 주요 동향
  • 동종 줄기세포 치료
  • 자가 줄기세포 치료

제5장 줄기세포 치료 시장 : 치료 영역별

  • 주요 동향
  • 종양학
  • 정형외과
  • 심혈관
  • 신경학
  • 기타

제6장 줄기세포 치료 시장 : 최종사용자별

  • 주요 동향
  • 병원
  • 클리닉
  • 기타

제7장 줄기세포 치료 시장 : 지역별

  • 주요 동향
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동/아프리카

제8장 기업 개요

  • 경쟁 대시보드
  • Astellas Pharma Inc
  • Capricor Therapeutics
  • Cellectis
  • Fujifilm Cellular Dynamics
  • ThermoGenesis Holdings, Inc
  • DiscGenics
  • Mesoblast Ltd
  • Novadip Biosciences
  • MEDIPOST
  • Takeda Pharmaceuticals
LSH 22.01.20

Data Tables

  • TABLE 1. Stem cell therapy market size, 2016 - 2027 (USD Million)
  • TABLE 2. Stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 3. Stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 4. Stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 5. Industry impact forces
  • TABLE 6. Allogenic stem cell therapy market size, by region, 2016 - 2027 (USD Million)
  • TABLE 7. Autologous stem cell therapy market size, by region, 2016 - 2027 (USD Million)
  • TABLE 8. Oncology market size, by region, 2016 - 2027 (USD Million)
  • TABLE 9. Orthopedic market size, by region, 2016 - 2027 (USD Million)
  • TABLE 10. Cardiovascular market size, by region, 2016 - 2027 (USD Million)
  • TABLE 11. Neurology size, by region, 2016 - 2027 (USD Million)
  • TABLE 12. Hospitals market size, by region, 2016 - 2027 (USD Million)
  • TABLE 13. Clinics size, by region, 2016 - 2027 (USD Million)
  • TABLE 14. Others market size, by region, 2016 - 2027 (USD Million)
  • TABLE 15. North America Stem cell therapy market size, by country, 2016 - 2027 (USD Million)
  • TABLE 16. North America stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 17. North America stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 18. North America stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 19. U.S. stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 20. U.S. stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 21. U.S. stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 22. Canada stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 23. Canada stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 24. Canada stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 25. Europe stem cell therapy market size, by country, 2016 - 2027 (USD Million)
  • TABLE 26. Europe stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 27. Europe stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 28. Europe stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 29. Germany stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 30. Germany stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 31. Germany stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 32. UK stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 33. UK stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 34. UK stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 35. France stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 36. France stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 37. France stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 38. Italy stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 39. Italy stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 40. Italy stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 41. Spain stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 42. Spain stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 43. Spain stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 44. Russia stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 45. Russia stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 46. Russia stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 47. Asia Pacific stem cell therapy market size, by country, 2016 - 2027 (USD Million)
  • TABLE 48. Asia Pacific stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 49. Asia Pacific stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 50. Asia Pacific stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 51. Japan stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 52. Japan stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 53. Japan stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 54. China stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 55. China stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 56. China stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 57. India stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 58. India stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 59. India stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 60. South Korea stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 61. South Korea stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 62. South Korea stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 63. Australia stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 64. Australia stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 65. Australia stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 66. Latin America stem cell therapy market size, by country, 2016 - 2027 (USD Million)
  • TABLE 67. Latin America stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 68. Latin America stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 69. Latin America stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 70. Brazil stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 71. Brazil stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 72. Brazil stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 73. Mexico stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 74. Mexico stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 75. Mexico stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 76. Argentina stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 77. Argentina stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 78. Argentina stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 79. MEA stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 80. MEA stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 81. MEA stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 82. Saudi Arabia stem cells therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 83. Saudi Arabia stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 84. Saudi Arabia stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 85. South Africa stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 86. South Africa stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 87. South Africa stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)
  • TABLE 88. UAE stem cell therapy market size, by type, 2016 - 2027 (USD Million)
  • TABLE 89. UAE stem cell therapy market size, by therapeutic area, 2016 - 2027 (USD Million)
  • TABLE 90. UAE stem cell therapy market size, by end-use, 2016 - 2027 (USD Million)

Charts & Figures

  • FIG 1. Stem cell therapy industry 360 degree synopsis, 2016 - 2027
  • FIG 2. Industry segmentation
  • FIG 3. Stem cell therapy market size, 2016 - 2027 (USD Million)
  • FIG 4. Growth potential analysis, by type
  • FIG 5. Growth potential analysis, by therapeutic area
  • FIG 6. Growth potential analysis, by end-use
  • FIG 7. Porter's analysis
  • FIG 8. Company matrix analysis, 2020
  • FIG 9. PESTEL analysis
  • FIG 10. Key segmental trends, by type
  • FIG 11. Key segmental trends, by therapeutic area
  • FIG 12. Key segmental trends, by end-use
  • FIG 13. Key regional trends
  • FIG 14. Competitive dashboard, 2020

The stem cell therapy market is anticipated to expand substantially by 2027 on account of ongoing R&D in the field and recent advancements in regenerative medicines across key regions.

Stem cells possess the ability to differentiate into a variety of different cell types. The key characteristics of stem cells include their ability to develop into a specific adult cell type and constant self-renewal. Stem cells are extensively used in tissue repair and regeneration owing to their ability to build every tissue in the human body.

Growing awareness and capabilities of healthcare institutions across developing economies, particularly regarding the benefits of stem cell therapy has fueled market expansion in recent years.

Several industry players have been engaging in profitable strategies to tap into emerging trends in the market, which has favorably impacted the overall business landscape. For instance, in July 2021, Astellas Pharma Inc., a global pharmaceutical company, announced a collaboration with Minovia Therapeutics, Ltd., a leading biotechnology company.

According to the terms of the deal, both firms have agreed to combine expertise to conduct R&D as well as the commercialization of novel cell therapy programs for diseases caused by mitochondrial dysfunction.

In another instance, in May 2021, FUJIFILM Cellular Dynamics, Inc., a prominent manufacturer of human cells for regenerative medicine applications, entered into an alliance with BlueRock Therapeutics LLC, a major biopharmaceutical company, and Opsis Therapeutics, LLC, a joint venture of FUJIFILM Cellular Dynamics and co-founder David Gamm. The alliance is intended to enable collaborative R&D efforts towards the development of cell therapies for eye diseases.

The stem cell therapy market has been categorized on the basis of type, end-use, therapeutic area, and regions. With respect to type, the market has further been divided into autologous and allogenic. The autologous sub-segment is expected to attain a valuation of around USD 11.0 billion by the end of 2027.

In terms of therapeutic area, the stem cell therapy market has been segmented into neurology, oncology, cardiovascular, orthopedic, and others. In 2020, the orthopedic sub-segment accounted for revenues worth nearly USD 850.5 million and is set to grow at a sturdy pace over the assessment period.

From the end-use perspective, the market has been bifurcated into clinics, hospitals, and others. The stem cell therapy market from the clinics sub-segment is speculated to amass significant gains by 2027, expanding at a pace of approximately 10.8% CAGR through the analysis timeline.

On the regional front, the Latin America stem cell therapy market held a market share of almost 7.4% in 2020 and is likely to showcase optimistic growth over the forecast timeframe.

The Middle East & Africa stem cell therapy market is poised to gain notable traction by 2027, growing at an impressive CAGR of over 10.5% through the study timeline.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definition
  • 1.2 Base estimates & working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East & Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Stem cell therapy industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Type trends
    • 2.1.3 Therapeutic area trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Stem Cell Therapy Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Advancements in regenerative medicine in North America & Europe
      • 3.3.1.2 Increasing government initiatives for stem cell therapy in developed as well as developing countries
      • 3.3.1.3 Rising awareness regarding availability of stem cell therapy in developing countries
      • 3.3.1.4 Growing prevalence of chronic diseases
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High cost of stem cell therapy
      • 3.3.2.2 Ethical issues associated with stem cell therapy
  • 3.4 Growth potential analysis
    • 3.4.1 By type
    • 3.4.2 By therapeutic area
    • 3.4.3 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Stem cell therapy ecosystem analysis
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2020
    • 3.8.1 Company matrix analysis
  • 3.9 PESTEL analysis

Chapter 4 Stem Cell Therapy Market, By Type

  • 4.1 Key segment trends
  • 4.2 Allogenic stem cell therapy
    • 4.2.1 Market size, by region, 2016-2027 (USD Million)
  • 4.3 Autologous stem cell therapy
    • 4.3.1 Market size, by region, 2016-2027 (USD Million)

Chapter 5 Stem Cell Therapy Market, By Therapeutic Area

  • 5.1 Key segment trends
  • 5.2 Oncology
    • 5.2.1 Market size, by region, 2016-2027 (USD Million)
  • 5.3 Orthopedic
    • 5.3.1 Market size, by region, 2016-2027 (USD Million)
  • 5.4 Cardiovascular
    • 5.4.1 Market size, by region, 2016-2027 (USD Million)
  • 5.5 Neurology
    • 5.5.1 Market size, by region, 2016-2027 (USD Million)
  • 5.6 Others
    • 5.6.1 Market size, by region, 2016-2027 (USD Million)

Chapter 6 Stem Cell Therapy Market, By End-use

  • 6.1 Key segment trends
  • 6.2 Hospitals
    • 6.2.1 Market size, by region, 2016-2027 (USD Million)
  • 6.3 Clinics
    • 6.3.1 Market size, by region, 2016-2027 (USD Million)
  • 6.4 Others
    • 6.4.1 Market size, by region, 2016-2027 (USD Million)

Chapter 7 Stem Cell Therapy Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2016-2027 (USD Million)
    • 7.2.2 Market size, by type, 2016-2027 (USD Million)
    • 7.2.3 Market size, by therapeutic area, 2016-2027 (USD Million)
    • 7.2.4 Market size, by end-use, 2016-2027 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by type, 2016-2027 (USD Million)
      • 7.2.5.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.2.5.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by type, 2016-2027 (USD Million)
      • 7.2.6.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.2.6.3 Market size, by end-use, 2016-2027 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2016-2027 (USD Million)
    • 7.3.2 Market size, by type, 2016-2027 (USD Million)
    • 7.3.3 Market size, by therapeutic area, 2016-2027 (USD Million)
    • 7.3.4 Market size, by end-use, 2016-2027 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by type, 2016-2027 (USD Million)
      • 7.3.5.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.3.5.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by type, 2016-2027 (USD Million)
      • 7.3.6.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.3.6.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by type, 2016-2027 (USD Million)
      • 7.3.7.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.3.7.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by type, 2016-2027 (USD Million)
      • 7.3.8.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.3.8.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.3.9 Spain
      • 7.3.9.1 Market size, by type, 2016-2027 (USD Million)
      • 7.3.9.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.3.9.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.3.10 Russia
      • 7.3.10.1 Market size, by type, 2016-2027 (USD Million)
      • 7.3.10.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.3.10.3 Market size, by end-use, 2016-2027 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2016-2027 (USD Million)
    • 7.4.2 Market size, by type, 2016-2027 (USD Million)
    • 7.4.3 Market size, by therapeutic area, 2016-2027 (USD Million)
    • 7.4.4 Market size, by end-use, 2016-2027 (USD Million)
    • 7.4.5 Japan
      • 7.4.5.1 Market size, by type, 2016-2027 (USD Million)
      • 7.4.5.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.4.5.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.4.6 China
      • 7.4.6.1 Market size, by type, 2016-2027 (USD Million)
      • 7.4.6.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.4.6.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by type, 2016-2027 (USD Million)
      • 7.4.7.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.4.7.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.4.8 South Korea
      • 7.4.8.1 Market size, by type, 2016-2027 (USD Million)
      • 7.4.8.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.4.8.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.4.9 Australia
      • 7.4.9.1 Market size, by type, 2016-2027 (USD Million)
      • 7.4.9.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.4.9.3 Market size, by end-use, 2016-2027 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2016-2027 (USD Million)
    • 7.5.2 Market size, by type, 2016-2027 (USD Million)
    • 7.5.3 Market size, by therapeutic area, 2016-2027 (USD Million)
    • 7.5.4 Market size, by end-use, 2016-2027 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by type, 2016-2027 (USD Million)
      • 7.5.5.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.5.5.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by type, 2016-2027 (USD Million)
      • 7.5.6.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.5.6.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by type, 2016-2027 (USD Million)
      • 7.5.7.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.5.7.3 Market size, by end-use, 2016-2027 (USD Million)
  • 7.6 MEA
    • 7.6.1 Market size, by country, 2016-2027 (USD Million)
    • 7.6.2 Market size, by type, 2016-2027 (USD Million)
    • 7.6.3 Market size, by therapeutic area, 2016-2027 (USD Million)
    • 7.6.4 Market size, by end-use, 2016-2027 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by type, 2016-2027 (USD Million)
      • 7.6.5.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.6.5.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by type, 2016-2027 (USD Million)
      • 7.6.6.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.6.6.3 Market size, by end-use, 2016-2027 (USD Million)
    • 7.6.7 UAE
      • 7.6.7.1 Market size, by type, 2016-2027 (USD Million)
      • 7.6.7.2 Market size, by therapeutic area, 2016-2027 (USD Million)
      • 7.6.7.3 Market size, by end-use, 2016-2027 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard
  • 8.2 Astellas Pharma Inc
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 Capricor Therapeutics
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Cellectis
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Fujifilm Cellular Dynamics
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 ThermoGenesis Holdings, Inc
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 DiscGenics
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Mesoblast Ltd
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Novadip Biosciences
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 MEDIPOST
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Takeda Pharmaceuticals
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
Back to Top
전화 문의
F A Q